Profil
Andy Seid joined Bioluminescence Ventures as a Partner in 2023.
Mr. Seid brings extensive experience spanning investment banking and operational expertise within the biopharmaceutical sector.
Prior to BLV, he served as director in the global healthcare group at Bank of America where he partnered with CEOs, CFOs and board members in identifying and executing financial and strategic outcomes through fundraising (IPOs, follow-ons, private placements) and M&A transactions.
He held similar roles at Leerink Partners and UBS and collectively has led over 50 completed transactions in the life sciences space.
As a biopharma operator, he has driven successful corporate, business development and strategic finance outcomes across small and large biopharmaceutical companies including at Genentech and Sangamo.
Andy holds a B.A.
with a double major in Molecular and Cell Biology and Economics from UC Berkeley.
Postes actifs de Randy Seidl
| Sociétés | Poste | Début |
|---|---|---|
| Sales Community LLC | Fondateur | 01/07/2020 |
Hanwha Impact Partners, Inc.
 Hanwha Impact Partners, Inc. Investment ManagersFinance Hanwha Impact Partners Inc (Hanwha Impact Partners) is a venture capital firm founded in 2022 by Kouki Harasaki. The firm is headquartered in San Francisco, California. | Private Equity Investor | 01/01/2023 |
Formation de Randy Seidl
| UC Berkeley College of Engineering | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
| Sales Community LLC | |
Hanwha Impact Partners, Inc.
Hanwha Impact Partners, Inc. Investment ManagersFinance Hanwha Impact Partners Inc (Hanwha Impact Partners) is a venture capital firm founded in 2022 by Kouki Harasaki. The firm is headquartered in San Francisco, California. | Finance |
